Tempus, UPenn Team Up to Improve Leukemia Treatment

News   Apr 28, 2017 | Original story from Tempus

 
Tempus, UPenn Team Up to Improve Leukemia Treatment
 
 
 

RELATED ARTICLES

Soft Power: The Rise of Bio-Friendly Robots

News

'Soft Robots' are a new development in robotics that aims to make human-friendly automation. These machines, made out of liquid-metals and polymer fibers, could help bring humans and robots closer together.

READ MORE

Antibody Drug-Conjugate to Target Treatment-Resistant Childhood Leukemia

News

Researchers have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.

READ MORE

Immune Cells Hold Promise In Slowing ALS

News

Recent research showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Informatics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE